Echo Street Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-6,612
| Closed | -$573K | – | 469 |
|
|
2023
Q2 | $573K | Buy |
6,612
+4,336
| +191% | +$376K | ﹤0.01% | 231 |
|
|
2023
Q1 | $221K | Buy |
+2,276
| New | +$221K | ﹤0.01% | 446 |
|
|
2022
Q4 | – | Sell |
-9,729
| Closed | -$825K | – | 506 |
|
|
2022
Q3 | $825K | Buy |
+9,729
| New | +$825K | 0.01% | 184 |
|
|
2022
Q2 | – | Sell |
-14,612
| Closed | -$1.13M | – | 573 |
|
|
2022
Q1 | $1.13M | Buy |
+14,612
| New | +$1.13M | 0.01% | 201 |
|
|
2021
Q3 | – | Sell |
-5,009
| Closed | -$418K | – | 635 |
|
|
2021
Q2 | $418K | Buy |
5,009
+1,730
| +53% | +$144K | ﹤0.01% | 415 |
|
|
2021
Q1 | $248K | Buy |
+3,279
| New | +$248K | ﹤0.01% | 456 |
|